Corporate greed of the week award goes to Flynn Pharma Epanutin capsules were costing the NHS just over £2m a year until Flynn Pharma, a British company, bought the rights to sell the anti-seizure medicine from Pfizer, repackaged it, and raised the price. Now the annual bill will be £46.6m. The extra money that will be spent on the drug could have paid for about 1,800 more nurses.
David Fakes, a director at Flynn Pharma, defended the price rise. He said: “It is a significant increase but to put it in context, it comes out at about 80p a dose. “The historical cost of Epanutin has been exceptionally low.”
Closely followed by the UK energy companies who have announced a 10% energy bill rise soon. Funny how they do that when the weather starts to get colder. Must just be a coincidence that it happens every year at this time.
http://www.bbc.co.uk/news/business-19927350
